{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["3D model", "CYP1A1", "Ca2+ release", "FAK", "MMP1", "flavonoids", "intravasation"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "29593542", "DateRevised": {"Year": "2024", "Month": "03", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "03", "Day": "14"}], "Language": ["eng"], "ELocationID": ["220", "10.3389/fphar.2018.00220"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "9", "PubDate": {"Year": "2018"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier <i>in Vitro</i>.", "Pagination": {"StartPage": "220", "MedlinePgn": "220"}, "Abstract": {"AbstractText": ["Flavonoids, present in fruits, vegetables and traditional medicinal plants, show anticancer effects in experimental systems and are reportedly non-toxic. This is a favorable property for long term strategies for the attenuation of lymph node metastasis, which may effectively improve the prognostic states in breast cancer. Hence, we studied two flavonoids, apigenin and luteolin exhibiting strong bio-activity in various test systems in cancer research and are readily available on the market. This study has further advanced the mechanistic understanding of breast cancer intravasation through the lymphatic barrier. Apigenin and luteolin were tested in a three-dimensional (3-D) assay consisting of MDA-MB231 breast cancer spheroids and immortalized lymph endothelial cell (LEC) monolayers. The 3-D model faithfully resembles the intravasation of breast cancer emboli through the lymphatic vasculature. Western blot analysis, intracellular Ca<sup>2+</sup> determination, EROD assay and siRNA transfection revealed insights into mechanisms of intravasation as well as the anti-intravasative outcome of flavonoid action. Both flavonoids suppressed pro-intravasative trigger factors in MDA-MB231 breast cancer cells, specifically MMP1 expression and CYP1A1 activity. A pro-intravasative contribution of FAK expression in LECs was established as FAK supported the retraction of the LEC monolayer upon contact with cancer cells thereby enabling them to cross the endothelial barrier. As mechanistic basis, MMP1 caused the phosphorylation (activation) of FAK at Tyr397 in LECs. Apigenin and luteolin prevented MMP1-induced FAK activation, but not constitutive FAK phosphorylation. Luteolin, unlike apigenin, inhibited MMP1-induced Ca<sup>2+</sup> release. Free intracellular Ca<sup>2+</sup> is a central signal amplifier triggering LEC retraction through activation of the mobility protein MLC2, thereby enhancing intravasation. FAK activity and Ca<sup>2+</sup> levels did not correlate. This implicates that the pro-intravasative contribution of FAK and of Ca<sup>2+</sup> release in LECs was independent of each other and explains the better anti-intravasative effects of luteolin <i>in vitro</i>. In specific formulations, flavonoid concentrations causing significant anti-intravasative effects, can certainly be achieved <i>in vivo</i>. As the therapeutic strategy has to be based on permanent flavonoid treatment both the beneficial and adverse effects have to be investigated in future studies."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Life Sciences, University of Vienna, Vienna, Austria."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Nanjing Medical University, Nanjing, China."}, {"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria."}], "LastName": "Hong", "ForeName": "Junli", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria."}, {"Identifier": [], "Affiliation": "Department for Clinical Pharmacy and Diagnostics, Faculty of Life Sciences, University of Vienna, Vienna, Austria."}, {"Identifier": [], "Affiliation": "Faculty of Pharmacy, Halu Oleo University, Kendari, Indonesia."}], "LastName": "Fristiohady", "ForeName": "Adryan", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria."}, {"Identifier": [], "Affiliation": "Department for Clinical Pharmacy and Diagnostics, Faculty of Life Sciences, University of Vienna, Vienna, Austria."}], "LastName": "Nguyen", "ForeName": "Chi H", "Initials": "CH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria."}], "LastName": "Milovanovic", "ForeName": "Daniela", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria."}], "LastName": "Huttary", "ForeName": "Nicole", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria."}], "LastName": "Krieger", "ForeName": "Sigurd", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Oncology, The 188th Hospital of People's Liberation Army of China, Chaozhou, China."}], "LastName": "Hong", "ForeName": "Junqiang", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria."}], "LastName": "Geleff", "ForeName": "Silvana", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria."}], "LastName": "Birner", "ForeName": "Peter", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department for Clinical Pharmacy and Diagnostics, Faculty of Life Sciences, University of Vienna, Vienna, Austria."}], "LastName": "J\u00e4ger", "ForeName": "Walter", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Science and Art, Adnan Menderes University, Aydin, Turkey."}], "LastName": "\u00d6zmen", "ForeName": "Ali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Life Sciences, University of Vienna, Vienna, Austria."}], "LastName": "Krenn", "ForeName": "Liselotte", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria."}], "LastName": "Krupitza", "ForeName": "Georg", "Initials": "G"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Akram M. (2013). Minireview on Achillea millefolium Linn. J. Membr. Biol. 246 661\u2013663. 10.1007/s00232-013-9588-x", "ArticleIdList": ["10.1007/s00232-013-9588-x", "23959026"]}, {"Citation": "Allen S. W., Mueller L., Williams S. N., Quattrochi L. C., Raucy J. (2001). The use of a high-volume screening procedure to assess the effects of dietary flavonoids on human CYP1A1 expression. Drug Metab. Dispos. 29 1074\u20131079.", "ArticleIdList": ["11454723"]}, {"Citation": "Amrutha K., Nanjan P., Shaji S. K., Sunilkumar D., Subhalakshmi K., Rajakrishna L., et al. (2014). Discovery of lesser known flavones as inhibitors of NF-\u03baB signaling in MDA-MB-231 breast cancer cells\u2013A SAR study. Bioorg. Med. Chem. Lett. 24 4735\u20134742. 10.1016/j.bmcl.2014.07.093", "ArticleIdList": ["10.1016/j.bmcl.2014.07.093", "25190466"]}, {"Citation": "Androutsopoulos V. P., Ruparelia K., Arroo R. R., Tsatsakis A. M., Spandidos D. A. (2009). CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells. Toxicology 264 162\u2013170. 10.1016/j.tox.2009.07.023", "ArticleIdList": ["10.1016/j.tox.2009.07.023", "19666078"]}, {"Citation": "Attoub S., Hassan A. H., Vanhoecke B., Iratni R., Takahashi T., Gaben A. M., et al. (2011). Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur. J. Pharmacol. 651 18\u201325. 10.1016/j.ejphar.2010.10.063", "ArticleIdList": ["10.1016/j.ejphar.2010.10.063", "21074525"]}, {"Citation": "Benedek B., Gjoncaj N., Saukel J., Kopp B. (2007). Distribution of phenolic compounds in Middleeuropean taxa of the Achillea millefolium L. aggregate. Chem. Biodivers. 4 849\u2013857. 10.1002/cbdv.200790072", "ArticleIdList": ["10.1002/cbdv.200790072", "17511000"]}, {"Citation": "Benetis R., Radusiene J., Janulis V. (2008). Variability of phenolic compounds in flowers of Achillea millefolium wild populations in Lithuania. Medicina 44 775\u2013781.", "ArticleIdList": ["19001835"]}, {"Citation": "Boire A., Covic L., Agarwal A., Jacques S., Sherifi S., Kuliopulos A. (2005). PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120 303\u2013313. 10.1016/j.cell.2004.12.018", "ArticleIdList": ["10.1016/j.cell.2004.12.018", "15707890"]}, {"Citation": "Breinholt V. M., Offord E. A., Brouwer C., Nielsen S. E., Br\u00f8sen K., Friedberg T. (2002). In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids. Food Chem. Toxicol. 40 609\u2013616. 10.1016/S0278-6915(01)00125-9", "ArticleIdList": ["10.1016/S0278-6915(01)00125-9", "11955666"]}, {"Citation": "Calderone V., Chericoni S., Martinelli C., Testai L., Nardi A., Morelli I., et al. (2004). Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels. Naunyn Schmiedebergs Arch. Pharmacol. 370 290\u2013298.", "ArticleIdList": ["15378228"]}, {"Citation": "Desai L. P., White S. R., Waters C. M. (2009). Mechanical stretch decreases FAK phosphorylation and reduces cell migration through loss of JIP3-induced JNK phosphorylation in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 297 520\u2013529. 10.1152/ajplung.00076.2009", "ArticleIdList": ["10.1152/ajplung.00076.2009", "PMC2739770", "19574423"]}, {"Citation": "Ding S. M., Zhang Z. H., Song J., Cheng X. D., Jiang J., Jia X. B. (2014). Enhanced bioavailability of apigenin via preparation of a carbon nanopowder solid dispersion. Int. J. Nanomed. 9 2327\u20132333. 10.2147/IJN.S60938", "ArticleIdList": ["10.2147/IJN.S60938", "PMC4026550", "24872695"]}, {"Citation": "Dioscurides P. (1st century A.D.) De Materia Medica, Copy from the 6th Century, Konstantinopel; Since 16th Century (by Emperor Ferdinand I) at the Department of Manuscripts and Rare Books Collection of the Austrian National Library. Vienna: Codex Vindobonensis med. Gr. 1."}, {"Citation": "Erdogan A., Most A. K., Wienecke B., Fehsecke A., Leckband C., Voss R., et al. (2007). Apigenin-induced nitric oxide production involves calcium-activated potassium channels and is responsible for antiangiogenic effects. J. Thromb. Haemost. 5 1774\u20131781. 10.1111/j.1538-7836.2007.02615.x", "ArticleIdList": ["10.1111/j.1538-7836.2007.02615.x", "17488347"]}, {"Citation": "Galindez J. D., Lanza A. M. D., Matellano L. F. (2002). Biologically active substances from the genus Scrophularia. Pharm. Biol. 40 45\u201399. 10.1076/phbi.40.1.45.5864", "ArticleIdList": ["10.1076/phbi.40.1.45.5864"]}, {"Citation": "Gasiorowska J., Teisseyre A., Uryga A., Michalak K. (2012). The influence of 8-prenylnaringenin on the activity of voltage-gated Kv1.3 potassium channels in human Jurkat T cells. Cell. Mol. Biol. Lett. 17 559\u2013570. 10.2478/s11658-012-0029-0", "ArticleIdList": ["10.2478/s11658-012-0029-0", "PMC6275880", "22933043"]}, {"Citation": "Giessrigl B., Yazici G., Teichmann M., Kopf S., Ghassemi S., Atanasov A. G., et al. (2012). Effects of Scrophularia extracts on tumor cell proliferation, death and intravasation through lymphoendothelial cell barriers. Int. J. Oncol. 40 2063\u20132074. 10.3892/ijo.2012.1388", "ArticleIdList": ["10.3892/ijo.2012.1388", "22367166"]}, {"Citation": "Hui C., Qi X., Qianyong Z., Xiaoli P., Jundong Z., Mantian M. (2013). Flavonoids, flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies. PLoS One 8:e54318. 10.1371/journal.pone.0054318", "ArticleIdList": ["10.1371/journal.pone.0054318", "PMC3548848", "23349849"]}, {"Citation": "Jiang H., Xia Q., Wang X., Song J., Bruce I. C. (2005). Luteolin induces vasorelaxion in rat thoracic aorta via calcium and potassium channels. Pharmazie 60 444\u2013447.", "ArticleIdList": ["15997834"]}, {"Citation": "Juncker-Jensen A., Deryugina E. I., Rimann I., Zajac E., Kupriyanova T. A., Engelholm L. H., et al. (2013). Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination. Cancer Res. 73 4196\u20134211. 10.1158/0008-5472.CAN-12-4495", "ArticleIdList": ["10.1158/0008-5472.CAN-12-4495", "PMC3754905", "23687338"]}, {"Citation": "Karin M. (2006). Nuclear factor-kappaB in cancer development and progression. Nature 441 431\u2013436. 10.1038/nature04870", "ArticleIdList": ["10.1038/nature04870", "16724054"]}, {"Citation": "Karin M., Greten F. R. (2005). NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5 749\u2013759. 10.1038/nri1703", "ArticleIdList": ["10.1038/nri1703", "16175180"]}, {"Citation": "Kerjaschki D., Bago-Horvath Z., Rudas M., Sexl V., Schneckenleithner C., Wolbank S., et al. (2011). Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J. Clin. Invest. 121 2000\u20132012. 10.1172/JCI44751", "ArticleIdList": ["10.1172/JCI44751", "PMC3083794", "21540548"]}, {"Citation": "Kim H. J., Lee S. B., Park S. K., Kim H. M., Park Y. I., Dong M. S. (2005). Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes. Arch. Pharm. Res. 28 1114\u20131121. 10.1007/BF02972971", "ArticleIdList": ["10.1007/BF02972971", "16276964"]}, {"Citation": "Lee S. T., Li Z., Wu Z., Aau M., Guan P., Karuturi R. K., et al. (2011). Context-specific regulation of NF-\u03baB target gene expression by EZH2 in breast cancers. Mol. Cell 43 798\u2013810. 10.1016/j.molcel.2011.08.011", "ArticleIdList": ["10.1016/j.molcel.2011.08.011", "21884980"]}, {"Citation": "Lewenhofer V., Schweighofer L., Lederm\u00fcller T., Eichsteininger J., K\u00e4hlig H., Zehl M., et al. (2018). Chemical composition of Scrophularia lucida and the effects on tumor invasiveness in vitro. Front. Pharmacol.", "ArticleIdList": ["PMC5891616", "29666580"]}, {"Citation": "Lin D., Kuang G., Wan J., Zhang X., Li H., Gong X., et al. (2017). Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of \u03b2-catenin expression. Oncol. Rep. 37 895\u2013902. 10.3892/or.2016.5311", "ArticleIdList": ["10.3892/or.2016.5311", "27959422"]}, {"Citation": "Lindenmeyer F., Li H., Menashi S., Soria C., Lu H. (2001). Apigenin acts on the tumor cell invasion process and regulates protease production. Nutr. Cancer 39 139\u2013147. 10.1207/S15327914nc391_19", "ArticleIdList": ["10.1207/S15327914nc391_19", "11588896"]}, {"Citation": "Liu Y., Xu X. H., Liu Z., Du X. L., Chen K. H., Xin X., et al. (2012). Effects of the natural flavone trimethylapigenin on cardiac potassium currents. Biochem. Pharmacol. 84 498\u2013506. 10.1016/j.bcp.2012.05.002", "ArticleIdList": ["10.1016/j.bcp.2012.05.002", "22583923"]}, {"Citation": "Murray A. T. (1924). The Iliad English trans. Homer Ph.D. in two volumes. Cambridge, MA: Harvard University Press."}, {"Citation": "Murray I. A., Patterson A. D., Perdew G. H. (2014). Aryl hydrocarbon receptor ligands in cancer: friend and foe. Nat. Rev. Cancer 14 801\u2013814. 10.1038/nrc3846", "ArticleIdList": ["10.1038/nrc3846", "PMC4401080", "25568920"]}, {"Citation": "Nguyen C. H., Brenner S., Huttary N., Atanasov A. G., Dirsch V. M., Chatuphonprasert W., et al. (2016a). AHR/CYP1A1 interplay triggers lymphatic barrier breaching in breast cancer spheroids by inducing 12(S)-HETE synthesis. Hum. Mol. Genet. 25 5006\u20135016. 10.1093/hmg/ddw329", "ArticleIdList": ["10.1093/hmg/ddw329", "28171546"]}, {"Citation": "Nguyen C. H., Brenner S., Huttary N., Li Y., Atanasov A. G., Dirsch V. M., et al. (2016b). 12(S)-HETE increases intracellular Ca2+ in lymph-endothelial cells disrupting their barrier function in vitro; stabilization by clinical drugs impairing calcium supply. Cancer Lett. 380 174\u2013183. 10.1016/j.canlet.2016.06.022", "ArticleIdList": ["10.1016/j.canlet.2016.06.022", "27390016"]}, {"Citation": "Nguyen C. H., Huttary N., Atanasov A. G., Chatuphonprasert W., Brenner S., Fristiohady A., et al. (2017). Fenofibrate inhibits tumor intravasation by several independent mechanisms in a 3-dimensional co-culture model. Int. J. Oncol. 50 1879\u20131888. 10.3892/ijo.2017.3956", "ArticleIdList": ["10.3892/ijo.2017.3956", "28393180"]}, {"Citation": "Nguyen C. H., Senfter D., Basilio J., Holzner S., Stadler S., Krieger S., et al. (2015). NF-\u03baB contributes to MMP1 expression in breast cancer spheroids causing paracrine PAR1 activation and disintegrations in the lymph endothelial barrier in vitro. Oncotarget 6 39262\u201339275. 10.18632/oncotarget.5741", "ArticleIdList": ["10.18632/oncotarget.5741", "PMC4770771", "26513020"]}, {"Citation": "Nguyen C. H., Stadler S., Brenner S., Huttary N., Krieger S., J\u00e4ger W., et al. (2016c). Cancer cell-derived 12(S)-HETE signals via 12-HETE receptor, RHO, ROCK and MLC2 to induce lymph endothelial barrier breaching. Br. J. Cancer 115 364\u2013370. 10.1038/bjc.2016.201", "ArticleIdList": ["10.1038/bjc.2016.201", "PMC4973159", "27362730"]}, {"Citation": "Qin Y., Zhao D., Zhou H. G., Wang X. H., Zhong W. L., Chen S., et al. (2016). Apigenin inhibits NF-\u03baB and snail signaling, EMT and metastasis in human hepatocellular carcinoma. Oncotarget 7 41421\u201341431. 10.18632/oncotarget.9404", "ArticleIdList": ["10.18632/oncotarget.9404", "PMC5173069", "27203387"]}, {"Citation": "Roberts R. E., Allen S., Chang A. P., Henderson H., Hobson G. C., Karania B., et al. (2013). Distinct mechanisms of relaxation to bioactive components from chamomile species in porcine isolated blood vessels. Toxicol. Appl. Pharmacol. 272 797\u2013805. 10.1016/j.taap.2013.06.021", "ArticleIdList": ["10.1016/j.taap.2013.06.021", "23845591"]}, {"Citation": "Schwock J., Dhani N., Hedley D. W. (2010). Targeting focal adhesion kinase signaling in tumor growth and metastasis. Expert Opin. Ther. Targets 14 77\u201394. 10.1517/14728220903460340", "ArticleIdList": ["10.1517/14728220903460340", "20001212"]}, {"Citation": "Sobin L. H., Gospodarowicz M. K., Wittekind C. (eds) (2009). TNM Classification of Malignant Tumours (UICC International Union against Cancer) 7th Edn. New York, NY: Wiley-Blackwell."}, {"Citation": "Stadler S., Nguyen C. H., Schachner H., Milovanovic D., Holzner S., Brenner S., et al. (2017). Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca2+ signaling. Cell. Mol. Life Sci. 74 1907\u20131921. 10.1007/s00018-016-2441-5", "ArticleIdList": ["10.1007/s00018-016-2441-5", "PMC5390003", "28013338"]}, {"Citation": "Teichmann M., Kretschy N., Kopf S., Jarukamjorn K., Atanasov A. G., Viola K., et al. (2014). Inhibition of tumor spheroid induced prometastatic intravasation gates in the lymph endothelial cell barrier by carbamazepine: drug testing in a 3D model. Arch. Toxicol. 88 691\u2013699.", "ArticleIdList": ["24352538"]}, {"Citation": "Teisseyre A., Michalak K. (2005). Genistein inhibits the activity of kv1.3 potassium channels in human T lymphocytes. J. Membr. Biol. 205 71\u201379. 10.1007/s00232-005-0764-5", "ArticleIdList": ["10.1007/s00232-005-0764-5", "16283587"]}, {"Citation": "Tsai P. H., Cheng C. H., Lin C. Y., Huang Y. T., Lee L. T., Kandaswami C. C., et al. (2016). Dietary flavonoids luteolin and quercetin suppressed cancer stem cell properties and metastatic potential of isolated prostate cancer cells. Anticancer Res. 36 6367\u20136380. 10.21873/anticanres.11234", "ArticleIdList": ["10.21873/anticanres.11234", "27919958"]}, {"Citation": "Viola K., Kopf S., Huttary N., Vonach C., Kretschy N., Teichmann M., et al. (2013). Bay11-7082 inhibits the disintegration of the lymphendothelial barrier triggered by MCF-7 breast cancer spheroids; the role of ICAM-1 and adhesion. Br. J. Cancer 108 564\u2013569. 10.1038/bjc.2012.485", "ArticleIdList": ["10.1038/bjc.2012.485", "PMC3593529", "23093227"]}, {"Citation": "Vogiatzoglou A., Mulligan A. A., Lentjes M. A., Luben R. N., Spencer J. P., Schroeter H., et al. (2015). Flavonoid intake in European adults (18 to 64 years). PLoS One 10:e0128132. 10.1371/journal.pone.0128132", "ArticleIdList": ["10.1371/journal.pone.0128132", "PMC4444122", "26010916"]}, {"Citation": "Vonach C., Viola K., Giessrigl B., Huttary N., Raab I., Kalt R., et al. (2011). NF-\u03baB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells. Br. J. Cancer 105 263\u2013271. 10.1038/bjc.2011.194", "ArticleIdList": ["10.1038/bjc.2011.194", "PMC3142797", "21629247"]}, {"Citation": "Wei J. F., Wei L., Zhou X., Lu Z. Y., Francis K., Hu X. Y., et al. (2008). Formation of Kv2.1-FAK complex as a mechanism of FAK activation, cell polarization and enhanced motility. J. Cell Physiol. 217 544\u2013557. 10.1002/jcp.21530", "ArticleIdList": ["10.1002/jcp.21530", "PMC2562431", "18615577"]}, {"Citation": "Woo H. D., Kim J. (2013). Dietary flavonoid intake and risk of stomach and colorectal cancer. World J. Gastroenterol. 19 1011\u20131019. 10.3748/wjg.v19.i7.1011", "ArticleIdList": ["10.3748/wjg.v19.i7.1011", "PMC3581988", "23467443"]}, {"Citation": "Wu H. J., Wu W., Sun H. Y., Qin G. W., Wang H. B., Wang P., et al. (2011). Acacetin causes a frequency- and use-dependent blockade of hKv1.5 channels by binding to the S6 domain. J. Mol. Cell. Cardiol. 51 966\u2013973. 10.1016/j.yjmcc.2011.08.022", "ArticleIdList": ["10.1016/j.yjmcc.2011.08.022", "21906601"]}, {"Citation": "Zhao G., Han X., Cheng W., Ni J., Zhang Y., Lin J., et al. (2017). Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells. Oncol. Rep. 37 2277\u20132285. 10.3892/or.2017.5450", "ArticleIdList": ["10.3892/or.2017.5450", "28260058"]}, {"Citation": "Zhou P., Li L. P., Luo S. Q., Jiang H. D., Zeng S. (2008). Intestinal absorption of luteolin from peanut hull extract is more efficient than that from individual pure luteolin. J. Agric. Food Chem. 56 296\u2013300. 10.1021/jf072612+", "ArticleIdList": ["10.1021/jf072612+", "18052241"]}, {"Citation": "Zhu B. H., Ma L., Pan X. D., Huang Y. L., Liu J. (2008). Scutellarin induced Ca2+ release and blocked KCl-induced Ca2+ influx in smooth muscle cells isolated from rat thoracic artery. J. Asian Nat. Prod. Res. 10 583\u2013589. 10.1080/10286020801966633", "ArticleIdList": ["10.1080/10286020801966633", "18470813"]}]}], "History": [{"Year": "2017", "Month": "10", "Day": "5"}, {"Year": "2018", "Month": "2", "Day": "27"}, {"Year": "2018", "Month": "3", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "3", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "3", "Day": "30", "Hour": "6", "Minute": "1"}, {"Year": "2018", "Month": "3", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["29593542", "PMC5861143", "10.3389/fphar.2018.00220"]}}]}